Megakaryocytes and beyond: The birth of platelets

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 6, 2003, Pages 1174-1182

  Italiano, J E ^a,b   Shivdasani, R A ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Megakaryocyte; Platelet assembly; Platelet biogenesis; Proplatelet; Thrombopoiesis

Indexed keywords

TRANSCRIPTION FACTOR;

CHEMISTRY; CYTOLOGY; CYTOSKELETON; HUMAN; MEGAKARYOCYTE; METABOLISM; PHYSIOLOGY; REVIEW; SECRETORY VESICLE; THROMBOCYTE; THROMBOCYTOPOIESIS;

BLOOD PLATELETS; CYTOSKELETON; HUMANS; MEGAKARYOCYTES; SECRETORY VESICLES; THROMBOPOIESIS; TRANSCRIPTION FACTORS;

EID: 2142699977     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00290.x     Document Type: Review

References (120)

1. Wright J. The origin and nature of blood platelets. Boston Med Surg J 1906; 154: 643-5.
2. Becker RP, DeBruyn PP. The transmural passage of blood cells into myeloid sinusoids and the entry of platelets into the sinusoidal circulation; a scanning electron microscopic investigation. Am J Anat 1976; 145: 1046-52.
3. Radley JM, Scurfield G. The mechanism of platelet release. Blood 1980; 56: 996-9.
4. Radley JM, Haller CJ. Fate of senescent megakaryocytes in the bone marrow. Br J Haematol 1983; 53: 277-87.
5. Leven RM. Megakaryocyte motility and platelet formation. Scanning Microsc 1987; 1: 1701-9.
6. Handagama PJ, Feldman BF, Jain NC, Farver TB, Kono CS. In vitro platelet release by rat megakaryocytes: effect of metabolic inhibitors and cytoskeletal disrupting agents. Am J Vet Res 1987; 48: 1142-6.
7. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1995; 85: 419-31.
8. Kaushansky K, Drachman JG. The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production. Oncogene 2002; 21: 3359-67.
9. Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW. Thrombocytopenia in c-mpl-deficient mice. Science 1994; 265: 1445-7.
10. Bunting S,Widmer R, Lipari T, Rangell L, Steinmetz H, Carver-Moore K, Moore MW, Keller GA, de Sauvage FJ. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin. Blood 1997; 90: 3423-9.
11. Choi ES, Nichol JL, Hokom MM, Hornkohl AC, Hunt P. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 1995; 85: 402-13.
12. Ito T, Ishida Y, Kashiwagi R, Kuriya S. Recombinant human c-Mpl ligand is not a direct stimulator of proplatelet formation of human megakaryocytes. Br J Haematol 1996; 94: 387-90.
13. Choi E. Regulation of proplatelet and platelet formation in vitro. In: Kuter, DJ, Hunt, P, Sheridan, W, Zucker-Franklin, D, eds. Thrombopoeisis and Thrombopoeitins: Molecular, Cellular, Preclinical, and Clinical Biology. Totowa, NJ: Humana Press, 1997: 271-84.
14. Odell T, Jackson C, Friday T. Megakaryocytopoiesis in rats with special reference to polyploidy. Blood 1970; 35: 775-82.
15. Ebbe S. Biology of megakaryocytes. Prog Hemost Thromb 1976; 3: 211-29.
16. Therman E, Sarto G, Stubblefiels P. Endomitosis: a reappraisal. Hum Genet 1983; 63: 13-8.
17. Raslova H, Roy L, Vourc'h C, Le Couedic JP, Brison O, Metivier D, Feunteun J, Kroemer G, Debili N, Vainchenker W. Megakaryocyte polyploidization is associated with a functional gene amplification. Blood 2003; 101: 541-4.
18. Nagata Y, Muro Y, Todokoro K. Thrombopoietin-induced polploidization of bone marrow megakaryocytes is due to a unique regulatory mechanism in late mitosis. J Cell Biol 1997; 139: 449-57.
19. Vitrat N, Cohen-Solal K, Pique C, Le Couedic JP, Norol F, Larsen AK, Katz A, Vainchenker W, Debili N. Endomitosis of human megakaryocytes is due to abortive mitosis. Blood 1998; 91: 3711-23.
20. Paulus J. DNA metabolism and development of organelles in guineaupig megakaryocytes: a combined ultrastructural, autoradiographic and cytophotometric study. Blood 1970; 35: 298-311.
21. Datta NS,Williams JL, Caldwell J, Curry AM, Ashcraft EK, Long MW. Novel alterations in CDK1/cyclin B1 kinase complex formation occur during the acquisition of a polyploid DNA content. Mol Biol Cell 1996; 7: 209-23.
22. Zhang Y, Wang Z, Ravid K. The cell cycle in polyploid megakaryocytes is associated with reduced activity of cyclin B1-dependent cdc2 kinase. J Biol Chem 1996; 271: 4266-72.
23. Wang Z, Zhang Y, Kamen D, Lees E, Ravid K. Cyclin D3 is essential for megakaryocytopoiesis. Blood 1995; 86: 3783-8.
24. Hayles J, Fisher D, Woodlard A. Temporal order of S phase and mitosis in fission yeast is determined by the state of the p34cdc22-mitotic B cyclin complex. Cell 1994; 78: 813-22.
25. Broek D, Bartlett R, Crawford K. Involvement of p34cdc2 in establishing the dependency of S phase on mitosis. Nature 1991; 349: 388-93.
26. Carow CE, Fox NE, Kaushansky K. Kinetics of endomitosis in primary murine megakaryocytes. J Cell Physiol 2001; 188: 291-303.
27. Zhang Y, Sun S, Chen WC, Kaluzhny Y, Chinnappan D, Yu G, Ravid K. Repression of AIM-1 kinase mRNA as part of a program of genes regulated by Mpl ligand. Biochem Biophys Res Commun 2001; 282: 844-9.
28. Kawasaki A, Matsumura I, Miyagawa J, Ezoe S, Tanaka H, Terada Y, Tatsuka M, Machii T, Miyazaki H, Furukawa Y, Kanakura Y. Downregulation of an AIM-1 kinase couples with megakaryocytic polyploidization of human hematopoietic cells. J Cell Biol 2001; 152: 275-87.
29. Masuda H, McDonald KL, Cande WZ. The mechanism of anaphase spindle elongation: uncoupling of tubulin incorporation and microtubule sliding during in vitro spindle reactivation. J Cell Biol 1988; 107: 623-33.
30. Nislow C, Lombillo VA, Kuriyama R, McIntosh J. A plus-end-directed motor enzyme that moves antiparallel microtubules in vitro localizes to the interzone of mitotic spindles. Nature (Lond) 1992; 359: 543-7.
31. Yamada F. The fine structure of the megakaryocyte in the mouse spleen. Acta Anat 1957; 29: 267-90.
32. Behnke O. An electron microscope study of megakaryocytes of rat bone marrow. I. The development of the demarcation membrane system and the platelet surface coat. J Ultrastuct Res 1968; 24: 412-33.
33. Nakao K, Angrist A. Membrane surface specialization of blood platelet and megakaryocyte. Nature 1968; 217: 960-1.
34. Bentfield-Barker ME, Bainton D. Ultrastructure of rat megakaryocytes after prolonged thrombocytopenia. J Ultrastruct Res 1977; 61: 201-14.
35. Shaklai M, Tavassoli M. Demarcation membrane system in rat megakaryocyte and the mechanism of platelet formation: a membrane reorganization process. J Ultrastruct Res 1978; 62: 270-85.
36. Radley JM, Haller CJ. The demarcation membrane system of the megakaryocyte: a misnomer? Blood 1982; 60: 213-9.
37. Daimon T, Gotoh Y. Cytochemical evidence of the origin of the dense tubular system in the mouse platelet. Histochemistry 1982; 76: 189-96.
38. Gerrard JM, White JG, Rao GH, Townsend D. Localization of platelet prostaglandin production in the platelet dense tubular system. Am J Pathol 1976; 101: 283-98.
39. Jones OP. Origin of megakaryocyte granules from Golgi vesicles. Anat Rec 1960; 138: 105-14.
40. Youssefian T, Cramer EM. Megakaryocyte dense granule components are sorted in multivesicular bodies. Blood 2000; 95: 4004-7.
41. Handagama P, George J, Shuman M, McEver RP, Bainton DF. Incorporation of circulating protein into megakaryocyte and platelet granules. Proc Natl Acad Sci USA 1987; 84: 861-5.
42. Coller BS, Seligsohn U, West SM, Scudder LE, Norton KJ.. Platelet fibrinogen and vitronectin in Glanzmann thrombasthenia: evidence consistent with specific roles for glycoprotein IIb/IIIA and alpha v beta 3 integrins in platelet protein trafficking. Blood 1991; 78: 2603-10.
43. Heijnen HF, Debili N, Vainchencker W, Breton-Gorius J, Geuze HJ, Sixma JJ. Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules. Blood 1998; 91: 2313-25.
44. King SM, Reed GL. Development of platelet secretory granules. Semin Cell Dev Biol 2002; 13: 293-302.
45. Swank RT, Novak EK, McGarry MP et al. Abnormal vesicular trafficking in mouse models of Hermansky-Pudlak syndrome. Pigment Cell Res 2000; 13: 59-67.
46. Zhang Q, Zhao B, Li W, Oiso N, Novak EK, Rusiniak ME, Gautam R, Chintala S, O'Brien EP, Zhang Y, Roe BA, Elliott RW, Eicher EM, Liang P, Kratz C, Legius E, Spritz RA, O'Sullivan TN, Copeland NG, Jenkins NA, Swank RT. Ru2 and Ru encode mouse orthologs of the genes mutated in human Hermansky-Pudlak syndrome types 5 and 6. Nat Genet 2003; 33: 145-53.
47. Huang L, Kuo YM, Gitschier J. The pallid gene encodes a novel, syntaxin 13-interacting protein involved in platelet storage pool deficiency. Nat Genet 1999; 23: 329-32.
48. Detter J, Zhang Q, Mules E, Novak EK, Mishra VS, Li W, McMurtrie EB, Tchernev VT, Wallace MR, Seabra MC, Swank RT, Kingsmore SF. Rab geranylgeranyl transferase alpha mutation in the gunmetal mouse reduces Rab prenylation and platelet synthesis. Proc Natl Acad Sci USA 2000; 97: 4144-9.
49. Swank R, Jiang S, Reddington M, Conway J, Stephenson D, McGarry MP, Novak EK. Inherited abnormalities in platelet organelles and platelet formation and associated altered expression of low molecular weight guanosine triphosphate-binding proteins in the mouse pigment mutant gunmetal. Blood 1993; 81: 2626-35.
50. Levin J. The evolution of mammalian platelets. In: Kuter DJ, Hunt P, Sheridan W, Zucker-Franklin D, eds. Thrombopoiesis and Thrombopoietins. Totowa, NJ: Humana Press, 1997: 63-78.
51. Lichtman MA, Chamberlain JK, Simon W, Santillo PA. Parasinusoidal location of megakaryocytes in marrow: a determinant of platelet release. Am J Hematol 1978; 4: 303-12.
52. Scurfield G, Radley JM. Aspects of platelet formation and release. Am J Hematol 1981; 10: 285-96.
53. Tavassoli M, Aoki M. Localization of megakaryocytes in the bone marrow. Blood Cells 1989; 15: 3-14.
54. Cramer EM, Norol F, Guichard J, Breton-Gorius J, Vainchenker W, Masse JM, Debili N. Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand. Blood 1997; 89: 2336-46.
55. Italiano JEJ, Lecine P, Shivdasani RA, Hartwig JH. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J Cell Biol 1999; 147: 1299-312.
56. Tablin F, Castro M, Leven RM. Blood platelet formation in vitro: the role of the cytoskeleton in megakaryocyte fragmentation. J Cell Sci 1990; 97: 59-70.
57. Miyazaki H, Inoue H, Yanagida M, Horie K, Mikayama T, Ohashi H, Nishikawa M, Suzuki T, Sudo T. Purification of rat megakaryocyte colony-forming cells using monoclonal antibody against rat platelet glycoprotein IIb/IIIa. Exp Hematol 1992; 20: 855-61.
58. Lecine P, Villeval J, Vyas P, Swencki B, Xu Y, Shivdasani RA. Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes. Blood 1998; 92: 1608-16.
59. Onodera K, Shavit JA, Motohashi H, Yamamoto M, Engel JD. Perinatal synthetic lethality and hematopoietic defects in compound mafG:mafK mutant mice. EMBO J 2000; 19: 1335-45.
60. Schwer HD, Lecine P, Tiwari S, Italiano JE Jr, Hartwig JH, Shivdasani RA. A lineage-restricted and divergent B-tubulin isoform is essential for the biogenesis, structure and function of blood platelets. Curr Biol 2001; 11: 579-86.
61. Thiery JB, Bessis M. Platelet genesis from megakaryocytes observed in live cells. Acad Sci 1956; 242: 290.
62. Behnke O. An electron microscope study of the rat megakaryocyte. II. Some aspects of platelet release and microtubules. J Ultrastruct Res 1969; 26: 111-29.
63. Hamada T, Mohle R, Hesselgesser J, Hoxie J, Nachman RL, Moore MA, Rafii S. Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J Exp Med 1998; 188: 539-48.
64. Riviere C, Subra F, Cohen-Solal K, Cordette-Lagarde V, Letestu R, Auclair C, Vainchenker W, Louache F. Phenotypic and functional evidence for the expression of CXCR receptor during megakaryocytopoiesis. Blood 1999; 93: 1511-23.
65. Kowalska MA, Ratajczak J, Hoxie J, Brass LF, Gewirtz A, Poncz M, Ratajczak MZ. Megakaryocyte precursors, megakaryocytes and platelets express the HIV co-receptor CXCR4 on their surface: determination of response to stromal-derived factor-1 by megakaryocytes and platelets. Br J Haematol 1999; 104: 220-9.
66. Minot G. Megakaryocytes in the peripheral circulation. J Exp Med 1922; 36: 1-4.
67. Melamed MR, Clifften EE, Mercer C, Koss G. The megakaryocyte blood count. Am J Med Sci 1966; 252: 301-9.
68. Hansen M, Pedersen NT. Circulating megakaryocytes in blood from the antecubital vein in healthy, adult human. Scand J Haematol 1978; 20: 371-6.
69. Handagama PJ, Feldman BF, Jain NC, Farver TB, Kono CS. Circulating proplatelets: isolation and quantitation in healthy rats and in rats with induced acute blood loss. Am J Vet Res 1987; 48: 962-5.
70. Tong M, Seth P, Penington DG. Proplatelets and stress platelets. Blood 1987; 69: 522-8.
71. Behnke O, Forer A. From megakaryocytes to platelets: platelet morphogenesis takes place in the bloodstream. Eur J Hematol 1998; 60 (Suppl): 3-23.
72. Kaufman RM, Airo R, Pollack S, Crosby WH. Circulating megakaryocytes and platelet release in the lung. Blood 1965; 26: 720-8.
73. Pederson NT. The pulmonary vessels as a filter for circulating megakaryocytes in rats. Scand J Haematol 1974; 13: 225-31.
74. Trowbridge EA, Martin JF, Slater DN. Evidence for a theory of physical fragmentation of megakaryocytes, implying that all platelets are produced in the pulmonary circulation. Thromb Res 1982; 28: 461-75.
75. Levine RF, Eldor A, Shoff PK, Kirwin S, Tenza D, Cramer EM. Circulating megakaryocytes. Delivery of large numbers of intact, mature megakaryocytes to the lungs. Eur J Hematol 1993; 51: 233-46.
76. Davis RE, Stenberg PE, Levin J, Beckstead JA. Localization of megakaryocytes in normal mice and following administration of platelet antiserum, 5-fluorouracil, or radiostrontium: evidence for the site of platelet production. Exp Hematol 1997; 25: 638-48.
77. Cramer L. Molecular mechanism of actin-dependent retrograde flow in lamellipodia of motile cells. Frontiers Bioscience 1997; 2: 260-70.
78. Davis E, Corash L, Baker G, Mok Y, Hill RJ, Levin J. Splenic thrombopoiesis after bone marrow ablation with radiostrontium: a murine model. J Lab Clin Med 1990; 116: 879-88.
79. Kelley MJ, Jawien W, Ortel TL, Korczak JF. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nat Genet 2000; 26: 106-8.
80. Seri M, Cusano R, Gangarossa S, Caridi G, Bordo D, Lo Nigro C, Ghiggeri GM, Ravazzolo R, Savino M, Del Vecchio M, d'Apolito M, Iolascon A, Zelante LL, Savoia A, Balduini CL, Noris P, Magrini U, Belletti S, Heath KE, Babcock M, Glucksman MJ, Aliprandis E, Bizzaro N, Desnick RJ, Martignetti JA. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium. Nat Genet 2000; 26: 103-5.
81. Kunishima S, Kojima T, Matsushita T, Tanaka T, Tsurusawa M, Furukawa Y, Nakamura Y, Okamura T, Amemiya N, Nakayama T, Kamiya T, Saito H. Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May- Haegglin anomaly/Sebastain syndrome). Blood 2001; 97: 1147-9.
82. May R. Leokozyteneinschlusse. Deutsch Arch Klin Med 1909; 96: 1-6.
83. Hegglin R. Gleichzeitige konstitutionelle Veranderungen an Neurtophilen und Thrombocyten. Helv Med Acta 1945; 12: 439-40.
84. Wang D, Villasante A, Lewis SA, Cowan NJ. The mammalian Btubulin repertoire: hematopoietic expression of a novel B-tubulin isotype. J Cell Biol 1985; 103: 1903-10.
85. White JG, Krivit W. An ultrastructural basis for the shape changes induced in platelets by chilling. Blood 1967; 30: 625-35.
86. White JG, Sauk JJ. The organization of microtubules and microtubule coils in giant platelet disorders. Am J Pathol 1984; 116: 514-22.
87. Fox JEB. Identification of actin-binding protein as the protein linking the membrane skeleton to glycoproteins on platelet plasma membrane. J Biol Chem 1985; 260: 11970-7.
88. Fox J, Aggerbeck L, Berndt M. Structure of the glycoprotein Ib-IX complex from platelet membranes. J Biol Chem 1988; 263: 4882-90.
89. Hartwig JH, DeSisto M. The cytoskeleton of the resting human blood platelet: structure of the membrane skeleton and its attachment to actin filaments. J Cell Biol 1991; 112: 407-25.
90. Lopez JA, Andrews RK, Afshar-Kharghan V, Berndt M. Bernard- Soulier syndrome. Blood 1998; 91: 4397-418.
91. Clemetson KJ, McGregor JL, James E, Dechavanne M, Luscher EF. Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surfacelabeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest 1982; 70: 304-11.
92. Nurden P, Nurden A. Giant platelets, megakaryocytes and the expression of glycoprotein Ib-IX complexes. C R Acad Sci Paris 1996; 319: 717-26.
93. Kass L, Leichtman DA, Beals TF. Megakaryocytes in the giant platelet syndrome. A cytochemical and ultrastructural study. Thromb Haemost 1977; 38: 652-9.
94. Ware J, Russel S, Ruggeri ZM. Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome. Blood 2000; 97: 2803-8.
95. Kanaji T, Russell S, Ware J. Amelioration of the macrothrombocytopenia associated with the murine Bernard-Soulier syndrome. Blood 2002; 100: 2102-7.
96. Zauli G, Vitale M, Falcieri E, Gibellini D, Bassini A, Celeghini C, Columbaro M, Capitani S. In vitro senescence and apoptotic cell death of human megakaryocytes. Blood 1997; 90: 2234-43.
97. Ryu KH, Chun S, Carbonierre S, Im SA, Kim HL, Shin MH, Shin HY, Ahn HS, Woo SY, Seoh JY, Fraser JK. Apoptosis and megakaryocytic differentiation during ex vivo expansion of human cord blood CD34+ cells using thrombopoietin. Br J Haematol 2001; 113: 470-8.
98. Li J, Kuter DJ. The end is just the beginning: megakaryocyte apoptosis and platelet release. Int J Hematol 2001; 74: 365-74.
99. Ogilvy S, Metcalf D, Print CG, Bath ML, Harris AW, Adams JM. Constitutive bcl-2 expression throughout the heamatopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci USA 1999; 96: 14943-8.
100. Bouillet P, Metcald D, Haung DCS, Tarlinton DM, Kay TW, Kontgen F, Adams JM, Strasser A. Proapoptotic bcl-2 relative Bim is required for certain apoptotic responses, leukocyte hemostasis, and to preclude autoimmunity. Science 1999; 286: 1735-8.
101. Kaluzhny Y, Yu G, Sun S, Toselli PA, Nieswandt B, JacksonCW, Ravid K. BclxL overexpression in megakaryocytes leads to impaired platelet fragmentation. Blood 2002; 100: 1670-8.
102. de Botton S, Sabri S, Daugas E, Zermati Y, Guidotti JE, Hermine O, Kroemer G, Vainchenker W, Debili N. Platelet formation is the consequence of caspase activation within megakaryocytes. Blood 2002; 100: 1310-7.
103. Shivdasani RA, Rosenblatt MF, Zucker-Franklin D, Jackson CW, Hunt P, Saris CJ, Orkin SH. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/ MGDF in megakaryocyte development. Cell 1995; 81: 695-704.
104. Lecine P, Italiano JEJ, Kim S, Villeval JL, Shivdasani RA. Hematopoietic-specific B1 tubulin participates in a pathway of platelet biogenesis dependent on the transcription factor NF-E2. Blood 2000; 96: 1366-73.
105. Shiraga M, Ritchie A, Aidoudi S, Baron V, Wilcox D, White G, Ybarrondo B, Murphy G, Leavitt A, Shattil S. Primary megakaryocytes reveal a role for transcription factor NF-E2 in integrin alpha IIb beta 3 signaling. J Cell Biol 1999; 147: 1419-29.
106. Deveaux S, Cohen-Kaminsky S, Shivdasani RA, Andrews NC, Filipe A, Kuzniak I, Orkin SH, Romeo PH, Mignotte V. p45 NF-E2 regulates expression of thromboxane synthase in megakaryocytes. EMBO J 1997; 16: 5654-61.
107. Yaekashiwa M, Wang LH. Transcriptional control of the human thromboxane synthase gene in vivo and in vitro. J Biol Chem 2002; 277: 22497-508.
108. Tsang AP, Fujiwara Y, Hom DB, Orkin SH. Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG. Genes Dev 1998; 12: 1176-88.
109. Chang AN, Cantor AB, Fujiwara Y, Lodish MB, Droho S, Crispino JD, Orkin SH. GATA-factor dependence of the multitype zinc-finger protein FOG-1 for its essential role in megakaryopoiesis. Proc Natl Acad Sci USA 2002; 99: 9237-42.
110. Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH. A lineageselective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J 1997; 16: 3965-73.
111. Vyas P, Ault K, Jackson C, Orkin SH, Shivdasani RA. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood 1999; 93: 2867-75.
112. Nichols KE, Crispino JD, Poncz M, White JG, Orkin SH, Maris JM, Weiss MJ. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet 2000; 24: 266-70.
113. Freson K, Devriendt K, Matthijs G, Van Hoof A, De Vos R, Thys C, Minner K, Hoylaerts MF, Vermylen J, Van Geet C. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood 2001; 98: 85-92.
114. Wang X, Crispino JD, Letting DL, Nakazawa M, Poncz M, Blobel GA. Control of megakaryocyte-specific gene expression by GATA-1 and FOG-1: role of Ets transcription factors. EMBO J 2002; 21: 5225-34.
115. Lemarchandel V, Ghysdael J, Mignotte V, Rahuel C, Romeo PH. GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression. Mol Cell Biol 1993; 13: 668-76.
116. Hart A, Melet F, Grossfeld P, Chien K, Jones C, Tunnacliffe A, Favier R, Bernstein A. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity 2000; 13: 167-77.
117. Spyropoulos DD, Pharr PN, Lavenburg KR, Jackers P, Papas TS, Ogawa M, Watson DK. Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol 2000; 20: 5643-52.
118. Kimura Y, Hart A, Hirashima M, Wang C, Holmyard D, Pittman J, Pang XL, Jackson CW, Bernstein A. Zinc finger protein, Hzf, is required for megakaryocyte development and hemostasis. J Exp Med 2002; 195: 941-52.
119. Hall MA, Curtis DJ, Metcalf D, Elefanty AG, Sourris K, Robb L, Gothert JR, Jane SM, Begley CG. The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12. Proc Natl Acad Sci USA 2003; 100: 992-7.
120. Mikkola HKA, Klintman J, Yang H, Hock H, Schlaeger TM, Fujiwara Y, Orkin SH. Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/ tal-1 gene. Nature 2003; 421: 547-51.